Advanced Ovarian Cancer Responds to Claudin-Targeted Drug in Preliminary Trial
Summary
Partial responses in half of patients with platinum-resistant disease, as crowded ADC list grows
Description
Partial responses in half of patients with platinum-resistant disease, as crowded ADC list grows
Original reporting
AFBytes is a read-only aggregator. Use the original source for full context and complete reporting.
Open original source